Sign in
4

Changes in Ownership

Viridian Therapeutics, Inc.\DE Filed Acc 0000950170-23-028724

Options or other derivatives

  • Director acquired 20,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Kiselak Tomas Director 2023-06-14 Grant or award · Stock Option (Right to Buy) +20,000 20,000 I: show line 1 in the form
Loading xslF345X04/ownership.xml…